Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arendals Fossekompani (AFK) is a Norwegian industrial investment company and green technology pioneer founded in 1896. Originally established as a hydropower producer, the company has evolved into a global investor focused on businesses that enable the energy transition and digital transformation. Its portfolio includes market-leading subsidiaries such as Volue (energy software), Tekna (advanced materials and 3D printing), ENRX (induction heating), and NSSLGlobal (satellite communications). Notably, its subsidiary Tekna produces high-purity spherical powders used in the manufacturing of medical implants and orthopedic devices. AFK is headquartered in Arendal, Norway, and has been listed on the Oslo Stock Exchange since 1913.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arendals Fossekompani.